{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"cerebrolysin","urls":{"read":"https://miscsubjects.com/api/articles/cerebrolysin/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/cerebrolysin/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/cerebrolysin/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/cerebrolysin/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/cerebrolysin/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/cerebrolysin/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/cerebrolysin/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"cerebrolysin","title":"cerebrolysin","register":"standard","tags":[],"updated_at":"2026-07-17T02:38:44.223Z","body_excerpt":"## Overview\nEvidence is being populated by Grok web search.","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39832667/","title":"The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts","quote":"CBL could be effective therapeutic strategy in preventing and treating VD by targeting neuroinflammation, BBB injury, and chronic cerebral hypoperfusion.","summary":"2025 review discussing Cerebrolysin (CBL) as a potential treatment for vascular dementia via anti-inflammatory and neuroprotective mechanisms.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"1286105d9a205b7bcfc12cc03292be2a61fe2fc4d85bcb1e972d89cdd39a4399"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39957612/","title":"Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study","quote":"Cerebrolysin combined with speech and language therapy offers promising potential for enhancing recovery in poststroke nonfluent aphasia.","summary":"2025 randomized pilot study (ESCAS) showing benefits of Cerebrolysin plus speech therapy for post-stroke aphasia recovery.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"b035aaffced9e5c80d38e031e91553022418dc7d2fe11d3967fcc875358b1c18"},{"id":"s3","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06897176","title":"Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia After Stroke","quote":"This study aims to measure changes in language ability after adding cerebrolysin to standard treatment for non-fluent aphasia patients with post-stroke ...","summary":"Ongoing 2025 clinical trial evaluating Cerebrolysin for language recovery in post-stroke non-fluent aphasia.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"ddcc96d4165b780c8a4220b08b6b5a8c02a1ce3bc0617f4e216ae07cc8e400d5"},{"id":"s4","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06677502","title":"Cerebrolysin in Critically Ill Patients With Delirium","quote":"Cerebrolysin, 50 mL daily administered intravenously for seven consecutive days, reduces or alleviates the severity of delirium detected by the CAM-ICU test.","summary":"2025 clinical trial testing Cerebrolysin for reducing delirium severity in critically ill patients.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"0ac9b7421280e331ebd53e60b0f2759d33fc5c14a43d379c7271b8093b3d5f22"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41018475/","title":"Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke","quote":"These findings suggest that Cerebrolysin significantly enhances early neurological recovery after ischemic stroke, with a comparable safety profile.","summary":"2025 study/meta-analysis supporting Cerebrolysin for improved neurorecovery post-ischemic stroke.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"e54f5ee0280583394277c94491345066bbc3ea46808106ab606a2e4f24bdde0b"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40851188/","title":"C-REGS2-A multinational, high-quality comparative ...","quote":"The results of the C-REGS2 study showed the effectiveness and safety of Cerebrolysin treatment for moderate acute IS in real-world clinical practice.","summary":"2025 real-world study (C-REGS2) confirming efficacy and safety of Cerebrolysin in acute ischemic stroke.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"71417b896315d9b314b4f68b02784ad9618d456cdfc55b17efb0f6977966d2e5"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40325343/","title":"Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study","quote":"Cerebrolysin improved functional outcomes at 90 days, accelerated neurological recovery, and reduced complications post-MT in patients with small ischemic core,","summary":"2025 study showing benefits of Cerebrolysin as add-on to mechanical thrombectomy in acute ischemic stroke.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"b7799f17e305d4ab9e3a15b82738f8dc174e29b9f9cdf4c953dc0e5b1a6b916c"},{"id":"s8","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41010922/","title":"Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study","quote":"Cerebrolysin, a neuropeptide with neuroprotective and neurotrophic properties, may enhance post-stroke recovery . This study evaluated the impact","summary":"2025 prospective observational study on Cerebrolysin adjuvant in acute ischemic stroke.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"4c40d8d18f06c59ba3cbf412398101cb9c308b3492ffdeae2d2445e9ba307b3e"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41349847/","title":"Cerebroprotection in acute ischemic stroke: Perspectives on combining Cerebrolysin with recanalization therapy","quote":"This article provides perspectives on the use of Cerebrolysin as an adjunct treatment to reperfusion therapy in acute ischemic stroke (AIS).","summary":"2025/2026 perspectives/review on Cerebrolysin with recanalization in AIS.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"b24406f09d2a34983eca65d5f3b458bd037f35c454c8570a508a9984120267d0"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39832667/","title":"The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts","quote":"CBL could be effective therapeutic strategy in preventing and treating VD by targeting neuroinflammation, BBB injury, and chronic cerebral hypoperfusion.","summary":"2025 review discussing Cerebrolysin (CBL) as a potential treatment for vascular dementia via anti-inflammatory and neuroprotective mechanisms.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"1286105d9a205b7bcfc12cc03292be2a61fe2fc4d85bcb1e972d89cdd39a4399"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39957612/","title":"Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study","quote":"Cerebrolysin combined with speech and language therapy offers promising potential for enhancing recovery in poststroke nonfluent aphasia.","summary":"2025 randomized pilot study (ESCAS) showing benefits of Cerebrolysin plus speech therapy for post-stroke aphasia recovery.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"b035aaffced9e5c80d38e031e91553022418dc7d2fe11d3967fcc875358b1c18"},{"id":"s3","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06897176","title":"Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia After Stroke","quote":"This study aims to measure changes in language ability after adding cerebrolysin to standard treatment for non-fluent aphasia patients with post-stroke ...","summary":"Ongoing 2025 clinical trial evaluating Cerebrolysin for language recovery in post-stroke non-fluent aphasia.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"ddcc96d4165b780c8a4220b08b6b5a8c02a1ce3bc0617f4e216ae07cc8e400d5"},{"id":"s4","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06677502","title":"Cerebrolysin in Critically Ill Patients With Delirium","quote":"Cerebrolysin, 50 mL daily administered intravenously for seven consecutive days, reduces or alleviates the severity of delirium detected by the CAM-ICU test.","summary":"2025 clinical trial testing Cerebrolysin for reducing delirium severity in critically ill patients.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"0ac9b7421280e331ebd53e60b0f2759d33fc5c14a43d379c7271b8093b3d5f22"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41018475/","title":"Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke","quote":"These findings suggest that Cerebrolysin significantly enhances early neurological recovery after ischemic stroke, with a comparable safety profile.","summary":"2025 study/meta-analysis supporting Cerebrolysin for improved neurorecovery post-ischemic stroke.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"e54f5ee0280583394277c94491345066bbc3ea46808106ab606a2e4f24bdde0b"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40851188/","title":"C-REGS2-A multinational, high-quality comparative ...","quote":"The results of the C-REGS2 study showed the effectiveness and safety of Cerebrolysin treatment for moderate acute IS in real-world clinical practice.","summary":"2025 real-world study (C-REGS2) confirming efficacy and safety of Cerebrolysin in acute ischemic stroke.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"71417b896315d9b314b4f68b02784ad9618d456cdfc55b17efb0f6977966d2e5"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40325343/","title":"Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study","quote":"Cerebrolysin improved functional outcomes at 90 days, accelerated neurological recovery, and reduced complications post-MT in patients with small ischemic core,","summary":"2025 study showing benefits of Cerebrolysin as add-on to mechanical thrombectomy in acute ischemic stroke.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"b7799f17e305d4ab9e3a15b82738f8dc174e29b9f9cdf4c953dc0e5b1a6b916c"},{"id":"s8","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41010922/","title":"Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study","quote":"Cerebrolysin, a neuropeptide with neuroprotective and neurotrophic properties, may enhance post-stroke recovery . This study evaluated the impact","summary":"2025 prospective observational study on Cerebrolysin adjuvant in acute ischemic stroke.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"4c40d8d18f06c59ba3cbf412398101cb9c308b3492ffdeae2d2445e9ba307b3e"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41349847/","title":"Cerebroprotection in acute ischemic stroke: Perspectives on combining Cerebrolysin with recanalization therapy","quote":"This article provides perspectives on the use of Cerebrolysin as an adjunct treatment to reperfusion therapy in acute ischemic stroke (AIS).","summary":"2025/2026 perspectives/review on Cerebrolysin with recanalization in AIS.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"b24406f09d2a34983eca65d5f3b458bd037f35c454c8570a508a9984120267d0"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"cerebrolysin","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":0,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":0,"claims_total":0,"sources":9,"anecdotal":0,"scientific":9,"user_reports":0,"questions":0,"evidence_ingests":0}}